"Big data" is being touted as having an important role to play in the treatment of cancer. But thus far it's mostly just talk, because the data are not being shared.
In a blog post on The Hill, Nancy G. Brinker, founder of the Susan G. Komen cancer charity, and Eric T. Rosenthal, a journalist who covers cancer, wrote that the promise of progress offered by big data has yet to be kept.
While the notion of the analysis of huge amounts of data to find trends, patterns, and associations that could be beneficial in developing better, more targeted therapies is an attractive one, and data collection continues apace by government, industry, and academia, the reality is that there are a number of obstacles preventing all the puzzle pieces from coming together.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
